XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock Including Additional Paid in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2021     5,816,991      
Balance at Dec. 31, 2021     $ 26,801 $ 105,681 $ 1,600 $ 134,082
Net income       18,626   18,626
Other comprehensive loss         (43,895) (43,895)
Cash dividends on common stock       (2,802)   (2,802)
Issuance of restricted shares (in shares)     1,650      
Exercise of stock options and tax effect (in shares)     30,075      
Exercise of stock options and tax effect     $ 277     277
Stock-based compensation expense     $ 162     162
Balance (in shares) at Sep. 30, 2022     5,848,716      
Balance at Sep. 30, 2022     $ 27,240 121,505 (42,295) 106,450
Balance (in shares) at Dec. 31, 2022     5,850,216      
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 $ (554) $ (554)        
Balance at Dec. 31, 2022     $ 27,372 128,388 (36,756) 119,004
Net income       22,255   22,255
Other comprehensive loss         (16,909) (16,909)
Cash dividends on common stock       (4,395)   (4,395)
Exercise of stock options and tax effect (in shares)     19,032      
Exercise of stock options and tax effect     $ 261     261
Stock-based compensation expense     $ 263     263
Termination of restricted shares (in shares)     (825)      
Balance (in shares) at Sep. 30, 2023     5,868,423      
Balance at Sep. 30, 2023     $ 27,896 $ 145,694 $ (53,665) $ 119,925